Location: Home
  • search
  • go
  • Relate News
  • 3/4/2026Eli Lilly Advances New Oral Diabetes Therapy in China
  • 3/4/2026Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...
  • 3/4/2026Antengene Strikes $1.1B+ CD19 T-Cell Engager Deal with UCB
  • 3/4/2026Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...
  • 3/4/2026Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...
  • 3/4/2026Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...
  • 3/4/2026CDE Issues Technical Guideline on Clinical Trials for Drugs Treating C...
  • 3/4/2026CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
  • 3/4/2026CSPC's Emicizumab Injection Receives Clinical Trial Approval in China
  • 3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
  • 3/3/2026China Approves Five NMEs in February as Innovation Expands Globally
  • 3/3/2026Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...
  • 3/3/2026Rallybio to Merge with Candid Therapeutics in $505M-Funded Reverse Mer...
  • 3/3/2026Clickmab Biotech Secures Seed+ Funding to Boost AI Antibody Design Pla...
  • 3/3/2026LongBio Pharma's LP‑003 Shows Superior Efficacy Over Xolair in Phase ...
  • 3/2/2026WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform
  • 3/2/2026Sanofi Secures Two New China Approvals for Dupilumab
  • 3/2/2026Innovent Registers Phase I Study for FIC Dual-Payload Bispecific ADC
  • 3/2/2026NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...
  • 3/2/2026NMPA Approves Rovalicitinib for First-Line Myelofibrosis
  • 3/2/2026QL Biopharm Raises Over CNY 500M in Series C Led by OrbiMed
  • 3/2/2026MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China
  • 3/2/2026RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA
  • 3/2/2026CDE Issues Interim Guidelines for Synthetic Oligonucleotide Innovativ...
  • 3/2/2026China Approves Jaypirca for Expanded Blood Cancer Indications
  • 3/2/20262026 Biotech Playbook: Hong Kong at the Centre of China’s Globalisati...
  • 2/28/2026bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
  • 2/28/2026China's Tech Giants Pour Billions Into AI Healthcare Amid Uncertain Bu...
  • 2/28/2026China-SCO Cooperation Center for Metabolic Diseases Launched in Shangh...
  • 2/28/2026Recent Executive Moves
  • Page:1/820 Total number of articles:24586: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group